Alenka Horvat Ledinek

Evaluating the effects of amantadin, modafinil and acetyl-l-carnitine on fatigue in multiple sclerosis – result of a pilot randomized, blind study

Alenka Horvat Ledinek, Mojca Čižek Sajko, Uroš Rot · Clinical Neurology and Neurosurgery · 2013 · 75 citations

Fatigue Management, Neurological Progress, Pharmacotherapy +5

Short-term impact of fampridine on motor and cognitive functions, mood and quality of life among multiple sclerosis patients

Katja Pavšič, Katarina Pelicon, Alenka Horvat Ledinek et al. · Clinical Neurology and Neurosurgery · 2015 · 50 citations

Neuropsychology, Multiple Sclerosis Patients, Neurological Functioning +10

Clinical, magnetic resonance imaging, cerebrospinal fluid and electrophysiological characteristics of the earliest multiple sclerosis

Uroš Rot, Alenka Horvat Ledinek, Saša Šega Jazbec · Clinical Neurology and Neurosurgery · 2008 · 26 citations

Neurophysiology, Cerebrospinal Fluid, Neurological Disorder +12

How Does Fingolimod (Gilenya®) Fit in the Treatment Algorithm for Highly Active Relapsing-Remitting Multiple Sclerosis?

Franz Fazekas, Ovidiu Băjenaru, Thomas Berger et al. · Frontiers in Neurology · 2013 · 25 citations · Full text

Interferons beta have vasoconstrictive and procoagulant effects: A woman who developed livedo reticularis and Raynaud phenomenon in association with interferon beta treatment for multiple sclerosis

Uroš Rot, Alenka Horvat Ledinek · Clinical Neurology and Neurosurgery · 2013 · 20 citations

Rheumatology, Interferon Beta Treatment, Autoimmune Disease +9